Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | engleski |
| Izdano: |
2018
|
| Online pristup: | https://doi.org/10.1016/j.ymthe.2018.06.008 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|